Wf. Lems et al., CHANGES IN (MARKERS OF) BONE METABOLISM DURING HIGH-DOSE CORTICOSTEROID PULSE TREATMENT IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Annals of the Rheumatic Diseases, 55(5), 1996, pp. 288-293
Objective-To examine the effect of high dose corticosteroid pulse trea
tment (three times 200 mg dexamethasone intravenously in eight days) o
n calcium and bone metabolism in 17 consecutive patients with active r
heumatoid arthritis (RA). Methods-Bone formation was quantified by mea
surement of serum alkaline phosphatase, osteocalcin, and carboxytermin
al propeptide of type I procollagen (pro-I-CPP) concentrations. Bone r
esorption was measured by urinary excretion of calcium, hydroxyproline
, (free and total) pyridinoline (Pyr), and serum concentrations of the
carboxyterminal cross linked telopeptide of type I collagen (I-CTP).
Disease activity of RA was measured by erythrocyte sedimentation rate,
C reactive protein, and Ritchie and Thompson joint scores. Results-Di
sease activity was initially high, and decreased during corticosteroid
pulse treatment and the following five weeks. Osteocalcin, alkaline p
hosphatase, and pro-I-CPP concentrations were initially within normal
limits, while I-CTP, Dpyr, and Pyr were increased. Osteocalcin and pro
-I-CPP concentrations decreased (p<0.01) during corticosteroid pulse t
reatment, but rapidly returned to baseline after the treatment. No cha
nges were observed in alkaline phosphatase and urinary excretion of ca
lcium and hydroxyproline. Bone resorption measured by serum I-CTP and
urinary excretion of Pyr and Dpyr was unchanged or decreased (p<0.05-0
.01), depending on the time of measurement and the parameter measured.
Conclusions-In these patients with active RA, bone resorption was inc
reased, while bone formation was within normal limits. During high dos
e corticosteroid pulse treatment, bone formation was only transiently
decreased, while markers of bone resorption were unchanged or decrease
d. Because corticosteroid pulse treatment has only a short term negati
ve effect on bone formation, and because it probably reduces bone reso
rption, at least partly as a result of the decreased disease activity,
the effect of corticosteroid pulse treatment on bone may be assumed t
o be relatively mild.